229 related articles for article (PubMed ID: 20844025)
1. Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.
Tomalik-Scharte D; Maiter D; Kirchheiner J; Ivison HE; Fuhr U; Arlt W
Eur J Endocrinol; 2010 Dec; 163(6):919-24. PubMed ID: 20844025
[TBL] [Abstract][Full Text] [Related]
2. Reduction in hepatic drug metabolizing CYP3A4 activities caused by P450 oxidoreductase mutations identified in patients with disordered steroid metabolism.
Flück CE; Mullis PE; Pandey AV
Biochem Biophys Res Commun; 2010 Oct; 401(1):149-53. PubMed ID: 20849814
[TBL] [Abstract][Full Text] [Related]
3. A rare cause of congenital adrenal hyperplasia: Antley-Bixler syndrome due to POR deficiency.
Herkert JC; Blaauwwiekel EE; Hoek A; Veenstra-Knol HE; Kema IP; Arlt W; Kerstens MN
Neth J Med; 2011 Jun; 69(6):281-3. PubMed ID: 21868813
[TBL] [Abstract][Full Text] [Related]
4. P450 oxidoreductase deficiency: a disorder of steroidogenesis with multiple clinical manifestations.
Miller WL
Sci Signal; 2012 Oct; 5(247):pt11. PubMed ID: 23092891
[TBL] [Abstract][Full Text] [Related]
5. Pubertal presentation in seven patients with congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.
Idkowiak J; O'Riordan S; Reisch N; Malunowicz EM; Collins F; Kerstens MN; Köhler B; Graul-Neumann LM; Szarras-Czapnik M; Dattani M; Silink M; Shackleton CH; Maiter D; Krone N; Arlt W
J Clin Endocrinol Metab; 2011 Mar; 96(3):E453-62. PubMed ID: 21190981
[TBL] [Abstract][Full Text] [Related]
6. Variability in human drug metabolizing cytochrome P450 CYP2C9, CYP2C19 and CYP3A5 activities caused by genetic variations in cytochrome P450 oxidoreductase.
Velazquez MNR; Parween S; Udhane SS; Pandey AV
Biochem Biophys Res Commun; 2019 Jul; 515(1):133-138. PubMed ID: 31128914
[TBL] [Abstract][Full Text] [Related]
7. P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms.
Burkhard FZ; Parween S; Udhane SS; Flück CE; Pandey AV
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):38-50. PubMed ID: 27068427
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19.
Agrawal V; Huang N; Miller WL
Pharmacogenet Genomics; 2008 Jul; 18(7):569-76. PubMed ID: 18551037
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 oxidoreductase deficiency: rare congenital disorder leading to skeletal malformations and steroidogenic defects.
Fukami M; Ogata T
Pediatr Int; 2014 Dec; 56(6):805-808. PubMed ID: 25294558
[TBL] [Abstract][Full Text] [Related]
10. Clinical and biochemical consequences of p450 oxidoreductase deficiency.
Flück CE; Pandey AV
Endocr Dev; 2011; 20():63-79. PubMed ID: 21164260
[TBL] [Abstract][Full Text] [Related]
11. P450 oxidoreductase deficiency - a new form of congenital adrenal hyperplasia.
Flück CE; Pandey AV; Huang N; Agrawal V; Miller WL
Endocr Dev; 2008; 13():67-81. PubMed ID: 18493134
[TBL] [Abstract][Full Text] [Related]
12. Combined phenotypic assessment of cytochrome p450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the "Cooperstown 5+1 cocktail".
Chainuvati S; Nafziger AN; Leeder JS; Gaedigk A; Kearns GL; Sellers E; Zhang Y; Kashuba AD; Rowland E; Bertino JS
Clin Pharmacol Ther; 2003 Nov; 74(5):437-47. PubMed ID: 14586384
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic challenges and management advances in cytochrome P450 oxidoreductase deficiency, a rare form of congenital adrenal hyperplasia, with 46, XX karyotype.
Wang C; Tian Q
Front Endocrinol (Lausanne); 2023; 14():1226387. PubMed ID: 37635957
[TBL] [Abstract][Full Text] [Related]
14. Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.
Krone N; Reisch N; Idkowiak J; Dhir V; Ivison HE; Hughes BA; Rose IT; O'Neil DM; Vijzelaar R; Smith MJ; MacDonald F; Cole TR; Adolphs N; Barton JS; Blair EM; Braddock SR; Collins F; Cragun DL; Dattani MT; Day R; Dougan S; Feist M; Gottschalk ME; Gregory JW; Haim M; Harrison R; Olney AH; Hauffa BP; Hindmarsh PC; Hopkin RJ; Jira PE; Kempers M; Kerstens MN; Khalifa MM; Köhler B; Maiter D; Nielsen S; O'Riordan SM; Roth CL; Shane KP; Silink M; Stikkelbroeck NM; Sweeney E; Szarras-Czapnik M; Waterson JR; Williamson L; Hartmann MF; Taylor NF; Wudy SA; Malunowicz EM; Shackleton CH; Arlt W
J Clin Endocrinol Metab; 2012 Feb; 97(2):E257-67. PubMed ID: 22162478
[TBL] [Abstract][Full Text] [Related]
15. In Silico Analysis of PORD Mutations on the 3D Structure of P450 Oxidoreductase.
Nurhafizuddin M; Azizi A; Ming LC; Shafqat N
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889519
[TBL] [Abstract][Full Text] [Related]
16. Novel phenotypes and genotypes in Antley-Bixler syndrome caused by cytochrome P450 oxidoreductase deficiency: based on the first cohort of Chinese children.
Fan L; Ren X; Song Y; Su C; Fu J; Gong C
Orphanet J Rare Dis; 2019 Dec; 14(1):299. PubMed ID: 31888681
[TBL] [Abstract][Full Text] [Related]
17. Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype.
McCammon KM; Panda SP; Xia C; Kim JJ; Moutinho D; Kranendonk M; Auchus RJ; Lafer EM; Ghosh D; Martasek P; Kar R; Masters BS; Roman LJ
J Biol Chem; 2016 Sep; 291(39):20487-502. PubMed ID: 27496950
[TBL] [Abstract][Full Text] [Related]
18. Effect of P450 oxidoreductase variants on the metabolism of model substrates mediated by CYP2C9.1, CYP2C9.2, and CYP2C9.3.
Subramanian M; Agrawal V; Sandee D; Tam HK; Miller WL; Tracy TS
Pharmacogenet Genomics; 2012 Aug; 22(8):590-7. PubMed ID: 22547083
[TBL] [Abstract][Full Text] [Related]
19. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
Streetman DS; Bleakley JF; Kim JS; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577
[TBL] [Abstract][Full Text] [Related]
20. Combined homozygous 21 hydroxylase with heterozygous P450 oxidoreductase mutation in a Saudi boy presented with hypertension.
Aljabri A; Alnaim F; Alsaleh Y
BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32994263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
